Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09LLS
|
|||
| Former ID |
DIB009716
|
|||
| Drug Name |
Havrix
|
|||
| Synonyms |
HAVsorbat SSW; Havrix Junior; Havrix Monodose; Hepatitis A vaccine, SB; HD-HAV-VAC
Click to Show/Hide
|
|||
| Indication | Hepatitis virus infection [ICD-11: 1E50-1E51; ICD-9: 573.3] | Approved | [1], [2] | |
| Company |
SmithKline Beecham plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT02124785) Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.